Imuldosa is the latest FDA-approved biosimilar of J&J’s blockbuster therapy for the treatment of certain autoimmune diseases.

The Cardiovascular and Renal Drugs Advisory Committee voted 10-6 in support of Stealth’s elamipretide for the ultra-rare ...

High-concentration monoclonal antibodies (mAbs) are gaining prominence given the compliance and cost advantages.

XtalPi's AI biologics discovery platform, XtalFold, has been licensed to Janssen Biotech for advanced biotherapeutics ...

Plaque psoriasis is a chronic condition that affects millions yet is often misunderstood or underappreciated in terms of its ...

Pfizer’s former CEO Ian Read and former CFO Frank D’Amelio now back the pharma, despite originally siding with Starboard.

KeyBioscience and Eli Lilly have extended their partnership to develop a new class of treatments for obesity and associated ...

Germany-based Merck KGaA has announced the launch of a new €290m ($317.6m) biosafety testing facility in Rockville, Maryland, ...

Boehringer Ingelheim and Circle Pharma have signed a partnership and licence agreement focused on developing a new cancer ...

Whilst the events do not outline any new safety risks, the data gives a new understanding of the link between oncogenesis and ...

At CPHI Europe, an expert discussed the promise of gummies as a drug delivery system and their unique manufacturing ...

Patient recruitment is a critical yet challenging phase in clinical trials. EMIS has been lauded for its significant ...